{"id":"https://openalex.org/A5155166149","orcid":"https://orcid.org/0000-0002-7185-4826","observed_orcids":["https://orcid.org/0000-0002-7185-4826"],"display_name":"Alexander A. Spasov","raw_author_names":["Alexander A. Spasov"],"full_name":"Alexander A. Spasov","works_count":2,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5155166149","orcid":"https://orcid.org/0000-0002-7185-4826","observed_orcids":["https://orcid.org/0000-0002-7185-4826"]},"affiliations":[{"institution":{"id":"https://openalex.org/I155623535","ror":"https://ror.org/04q6a0352","display_name":"Volgograd State Medical University","country_code":"RU","type":"education","lineage":["https://openalex.org/I155623535"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I155623535","ror":"https://ror.org/04q6a0352","display_name":"Volgograd State Medical University","country_code":"RU","type":"education","lineage":["https://openalex.org/I155623535"]}],"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":2,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","count":2,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","count":1,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","count":1,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","value":9.9e-06,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","value":5.6e-06,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","value":4.4e-06,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","value":3.6e-06,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.7889999747276306},{"id":"2778484023","wikidata":"https://www.wikidata.org/wiki/Q415190","display_name":"Benzimidazole","score":0.7513999938964844},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.6556000113487244},{"id":"116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","score":0.5178999900817871},{"id":"202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","score":0.39250001311302185}],"counts_by_year":[{"year":2026,"works_count":2,"oa_works_count":2,"cited_by_count":0}],"display_name_alternatives":["Alexander A. Spasov"],"block_key":"a spasov","works_api_url":"https://api.openalex.org/works?filter=author.id:A5155166149","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5155166149","updated_date":"2026-11-14T11:48:19","created_date":"2026-10-03T00:00:00"}
